Sangamo Therapeutics, Inc. revenue breakdown overview

Sangamo Therapeutics, Inc. revenue for the last year amounted to 176.23 M USD, the most of which — 176.23 M USD — came from its highest performing source at the moment, Zinc Finger Protein, the year earlier bringing 111.30 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Sangamo Therapeutics, Inc. 176.23 M USD, and the year before that — 111.30 M USD.